APYX vs ARAY

Apyx Medical Corporation vs Accuray Incorporated — Valuation Comparison 2026

By CirclFi Research Team · Updated 2026-06-01 · Data from SEC EDGAR, FRED & GDELT

Quick Summary — APYX scores higher on quality with 6.5/10 vs ARAY's 4.3/10. APYX trades at $3.96 while ARAY trades at $0.39. Both analyzed daily using SEC EDGAR data across 13 institutional models.

APYX

Medical Devices
Apyx Medical Corporation
Quality
6.5
out of 10
Value Trap
12
SAFE
Price
$3.96
Last close
Models
10/13
Active
VS

ARAY

Medical Devices
Accuray Incorporated
Quality
4.3
out of 10
Value Trap
12
SAFE
Price
$0.39
Last close
Models
5/13
Active
APYX
2 models active
Limited to 2/13 visible models
ARAY
Earnings Power Value sees +41.4% upside
Quality 4.3/10 — below average

APYX vs ARAY — Fair Value Comparison

APYX
$0$2$3$5 Price$3.96 Bayesian …$1.06 (-73.1%) Earnings …$0.73 (-76.0%)
ARAY
$0$0$1$1 Price$0.39 Earnings …$0.66 (+41.4%) ML-RIV$0.03 (-93.5%)
Market Price Model 1 Model 2

Model-by-Model Comparison

ModelType APYX Fair ValueAPYX Upside ARAY Fair ValueARAY Upside
Bayesian DCF Intrinsic $1.06 -73.1% — —
Earnings Power Value Intrinsic $0.73 -76.0% $0.66 +41.4%
EROIC Spread Intrinsic $•••.•• ••.•% $•••.•• ••.•%
First Chicago Scenario $•••.•• ••.•% $•••.•• ••.•%
ML-RIV Intrinsic — — $0.03 -93.5%
Dynamic NAV Asset-Based $•••.•• ••.•% $•••.•• ••.•%
PWERM Option-Based $•••.•• ••.•% $•••.•• ••.•%
Regime Cross-Sectional Relative $•••.•• ••.•% $•••.•• ••.•%
Sentiment SOTP Hybrid $•••.•• ••.•% $•••.•• ••.•%
CUCE Ensemble Ensemble $•••.•• ••.•% $•••.•• ••.•%
FTNN Topology Relative $•••.•• ••.•% $•••.•• ••.•%

APYX vs ARAY — Which Stock Is More Undervalued in 2026?

APYX scores higher with a 6.5/10 quality rating vs ARAY's 4.3/10. Both stocks are analyzed daily using SEC EDGAR filings across 13 independent models.

How Do APYX and ARAY Valuations Compare?

APYX currently trades at $3.96 while ARAY trades at $0.39. CirclFi's engine processes SEC EDGAR 10-K and 10-Q filings, FRED macroeconomic data, and GDELT news sentiment to generate independent fair value estimates daily for both companies.

Quality of Company: APYX vs ARAY

APYX earns a Quality of Company score of 6.5/10 compared to ARAY's 4.3/10. This moderate difference suggests one company has an edge in fundamental quality, though both may offer investment merit depending on valuation. The QOC score synthesizes 32 signals spanning profitability margins, revenue growth, free cash flow, capital allocation, and leverage.

Value Trap Risk: APYX vs ARAY

APYX carries a SAFE value trap risk (12/100) while ARAY shows SAFE risk (12/100). Both companies show manageable value trap risk, suggesting their current valuations are not artificially depressed by fundamental deterioration.

Both in Medical Devices

Both APYX and ARAY operate in Medical Devices, which has 10 stocks tracked by CirclFi. Same-industry comparisons provide the most direct insight into relative valuation since both companies face similar regulatory environments, market dynamics, and competitive pressures. Both companies are analyzed with models spanning intrinsic (Bayesian DCF, EPV), scenario-based (First Chicago), regime-switching (Markov DDM, RCMH-DCF), machine learning (ML-RIV, FTNN), and ensemble methods (CUCE).

2 of 13 MODELS UNLOCKED

You’re comparing 2 models. 11 more have an opinion.

11 hidden models compare APYX vs ARAY differently — including EROIC Spread, First Chicago, Markov DDM, PWERM, and 7 more. Some may disagree with the 2 you see above.

11 additional fair values per stock Full confidence breakdown Live terminal — 5,000+ stocks

Bloomberg Terminal: ~$2,000/mo  ·  FactSet: ~$1,000/mo  ·  CirclFi: $0.90/day

See All 13 Models — $0.90/day

We don’t predict prices. We show you what 13 independent mathematical frameworks say a stock is worth — and let you decide.

APYX
View Full Apyx Medical Corporation Analysis →
ARAY
View Full Accuray Incorporated Analysis →